Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05346588 · ClinicalTrials.gov registry record · Phase 3
THRIVE Feasibility Trial
A Phase 3 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
NCT05346588 is a Phase 3 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 300 participants.
The verdict
NCT05346588, a Phase 3 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
Study Summary
To evaluate the feasibility of a pragmatic, large scale, comparative effectiveness, randomized evaluation of patient experience of intravenous propofol versus inhaled volatile anesthesia.
Interventions
- OTHER Anesthetic technique Propofol TIVA
- OTHER Anesthetic technique inhaled agent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-09-29 |
| Est. Completion | 2023-06-28 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05346588
The ClinicalTrials.gov registry entry for NCT05346588 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Anesthetic technique Propofol TIVA is the first listed.
NCT05346588 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05346588 about?
NCT05346588 is a clinical study titled "THRIVE Feasibility Trial". To evaluate the feasibility of a pragmatic, large scale, comparative effectiveness, randomized evaluation of patient experience of intravenous propofol versus inhaled volatile anesthesia.
What is the current status of trial NCT05346588?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2022-09-29. Estimated completion is 2023-06-28.
What interventions are being tested in trial NCT05346588?
The interventions under investigation include: Anesthetic technique Propofol TIVA (OTHER), Anesthetic technique inhaled agent (OTHER).
Who is sponsoring clinical trial NCT05346588?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.